DST Systems Inc. (NYSE:DST) will release its financial results for the fourth quarter and year ended December 31, 2010, on Monday, February 7, 2011, after the close of trading on the New York Stock Exchange. The Company will host a conference call on Tuesday, February 8, 2011, at 10:00 A.M. Central Time. The dial-in number for domestic callers is (800) 230-1093 and for international callers is (612) 332-0107. Callers should reference the Fourth Quarter Earnings Release. A telephone replay of the call will be available from February 8, 2011, at 12:00 P.M. through February 15, 2011 at 11:59 P.M. The replay number for domestic callers is (800) 475-6701, and for international callers is (320) 365-3844, with the access code of 188598. Interested parties may listen to the conference call via a live webcast from the DST Systems, Inc. web site www.dstsystems.com.
DST Systems, Inc. provides information processing, and computer software services and products. It operates in two segments, Financial Services and Output Solutions.
Power3 Medical Products, Inc. (OTCBB:PWRM) recently disclosed that Power3 delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroProÂ®, Power3's diagnostic test, and focused on Power3's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
"In preparation for commercialization, our objective at this meeting was to show how Power3's protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer's disease," said Dr. Ira L. Goldknopf, Power3's President and Chief Scientific Officer. "It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3's protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs."
Power3 has filed several patent applications for its NuroProÂ® technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.
"We are pleased that our blood tests specifically diagnose Alzheimer's in patients, both pre- and post-treatment," said Helen R. Park, MS, Chief Executive Officer of Power3, "and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii."
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.
Through these processes, Power3 has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which Power3 has completed Phase I clinical trials, and NuroProÂ®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, for which Power3 is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
For more information, please visit http://www.power3medical.com.
Orofino Gold Corp. (PINK:ORFG) has several Gold development properties in Colombia, a current hot spot of gold production in the world markets. The early adopters, who wisely purchased their positions before the masses come, will sleep well at night while others fret and worry as they watch the purchasing power of their savings evaporate like water in the desert.
Gold offers a safe way to hedge against these falling fait currencies (backed by faith and nothing else). But for a little more leverage and a lot more profit potential invest in a junior gold stock. Gold's Usefulness as safe haven: The geo-political and world economic structure is currently undergoing major change-some have even called the situation an "upheaval." This means that the investment outlook, particularly for certain parts of the world, is more unpredictable than usual. Under these circumstances, it is logical to conclude that certain investment portfolios should include real (non-paper) assets such as commodities for protection against a potential decline in the paper markets.
The opportunity looks like this
.Orofino Gold Corp. with 1 million ounces; the share price would be with (80,000,000 shrs out) 1 million ounce at a conservative $1,000 = $ 1 billion divided by 80 million shares = $12.50/share (Orofino has only 60,000,000 shrs outstanding now): 2 million ounces (100,000,000 shares) = $ 2 billion divided by 100,000,000 = $20/share; and 4 million ounces (110,000,000 shares) = $ 4 billion divided by 110,000,000 = $36/share.
It is reasonably believed that the five plus high grade producing gold targets will produce 1+ million ounces each and with Silver and Copper credits the formulae above would be conservative. Gold is the most malleable and ductile of all metals; a single gram can be beaten into a sheet of 1 square meter, or an ounce into 300 square feet. Gold leaf can be beaten thin enough to become translucent. The transmitted light appears greenish blue, because gold strongly reflects yellow and red. Such semi-transparent sheets also strongly reflect infrared light, making them useful as infrared (radiant heat) shields in visors of heat-resistant suits, and in sun-visors for spacesuits.
Orofino Gold Corp. is a China based gold producer with one producing gold mine in Colombia and an option on a strong portfolio of small producers and development/exploration assets in Colombia.
For more information about this company please visit http://www.orofinogold.com
Colgate-Palmolive Co. (NYSE:CL) declared quarterly cash dividends of $.53 per common share, payable on February 15, 2011, to shareholders of record on January 25, 2011. The Company has paid uninterrupted dividends on its common stock since 1895. About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition.
Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Elmex, Tom's of Maine, Ajax, Axion, Soupline, and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and markets consumer products worldwide.
Tanger Factory Outlet Centers Inc. (NYSE:SKT) will be released Tuesday evening, February 22, 2011 after the market close. The Company will host its conference call for analysts, investors and other interested parties on Wednesday, February 23, 2011 at 10:00 a.m. eastern time. To access the conference call, listeners should dial 1-877-277-5113 on Wednesday, February 23, 2011 and request to be connected to the Tanger Factory Outlet Centers Fourth Quarter and Year End 2010 Financial Results call.
Tanger Factory Outlet Centers, Inc. operates as a real estate investment trust (REIT). The company, through its subsidiary, Tanger Properties Limited Partnership, engages in acquiring, developing, owning, operating, and managing factory outlet shopping centers.
Sign-Up For Free Hot Stock Alerts At http://stockhottips.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. StockHotTips.com.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold StockHotTips.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stockhottips.com/disclaimer)Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.
Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.